167 related articles for article (PubMed ID: 20499370)
1. Elevated serum IGF-1 levels synergize PTH action on the skeleton only when the tissue IGF-1 axis is intact.
Elis S; Courtland HW; Wu Y; Fritton JC; Sun H; Rosen CJ; Yakar S
J Bone Miner Res; 2010 Sep; 25(9):2051-8. PubMed ID: 20499370
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy-associated plasma protein-A modulates the anabolic effects of parathyroid hormone in mouse bone.
Clifton KB; Conover CA
Bone; 2015 Dec; 81():413-416. PubMed ID: 26297833
[TBL] [Abstract][Full Text] [Related]
3. Elevated serum levels of IGF-1 are sufficient to establish normal body size and skeletal properties even in the absence of tissue IGF-1.
Elis S; Courtland HW; Wu Y; Rosen CJ; Sun H; Jepsen KJ; Majeska RJ; Yakar S
J Bone Miner Res; 2010 Jun; 25(6):1257-66. PubMed ID: 20200935
[TBL] [Abstract][Full Text] [Related]
4. The ternary IGF complex influences postnatal bone acquisition and the skeletal response to intermittent parathyroid hormone.
Yakar S; Bouxsein ML; Canalis E; Sun H; Glatt V; Gundberg C; Cohen P; Hwang D; Boisclair Y; Leroith D; Rosen CJ
J Endocrinol; 2006 May; 189(2):289-99. PubMed ID: 16648296
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone.
Bikle DD; Sakata T; Leary C; Elalieh H; Ginzinger D; Rosen CJ; Beamer W; Majumdar S; Halloran BP
J Bone Miner Res; 2002 Sep; 17(9):1570-8. PubMed ID: 12211426
[TBL] [Abstract][Full Text] [Related]
6. PTH ameliorates acidosis-induced adverse effects in skeletal growth centers: the PTH-IGF-I axis.
Green J; Goldberg R; Maor G
Kidney Int; 2003 Feb; 63(2):487-500. PubMed ID: 12631114
[TBL] [Abstract][Full Text] [Related]
7. Gender differences in the response of CD-1 mouse bone to parathyroid hormone: potential role of IGF-I.
Wang Y; Sakata T; Elalieh HZ; Munson SJ; Burghardt A; Majumdar S; Halloran BP; Bikle DD
J Endocrinol; 2006 May; 189(2):279-87. PubMed ID: 16648295
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone mediates pubertal skeletal development independent of hepatic IGF-1 production.
Courtland HW; Sun H; Beth-On M; Wu Y; Elis S; Rosen CJ; Yakar S
J Bone Miner Res; 2011 Apr; 26(4):761-8. PubMed ID: 20928887
[TBL] [Abstract][Full Text] [Related]
9. Increased serum IGF-1 levels protect the musculoskeletal system but are associated with elevated oxidative stress markers and increased mortality independent of tissue igf1 gene expression.
Elis S; Wu Y; Courtland HW; Sun H; Rosen CJ; Adamo ML; Yakar S
Aging Cell; 2011 Jun; 10(3):547-50. PubMed ID: 21418509
[TBL] [Abstract][Full Text] [Related]
10. Reduced Serum IGF-1 Associated With Hepatic Osteodystrophy Is a Main Determinant of Low Cortical but Not Trabecular Bone Mass.
Liu Z; Han T; Werner H; Rosen CJ; Schaffler MB; Yakar S
J Bone Miner Res; 2018 Jan; 33(1):123-136. PubMed ID: 28902430
[TBL] [Abstract][Full Text] [Related]
11. Role of IGF-I on PTH effects on bone.
Lombardi G; Di Somma C; Vuolo L; Guerra E; Scarano E; Colao A
J Endocrinol Invest; 2010; 33(7 Suppl):22-6. PubMed ID: 20938222
[TBL] [Abstract][Full Text] [Related]
12. Insulin receptor substrate-1 is required for bone anabolic function of parathyroid hormone in mice.
Yamaguchi M; Ogata N; Shinoda Y; Akune T; Kamekura S; Terauchi Y; Kadowaki T; Hoshi K; Chung UI; Nakamura K; Kawaguchi H
Endocrinology; 2005 Jun; 146(6):2620-8. PubMed ID: 15718274
[TBL] [Abstract][Full Text] [Related]
13. The roles of parathyroid hormone in bone remodeling: prospects for novel therapeutics.
Lombardi G; Di Somma C; Rubino M; Faggiano A; Vuolo L; Guerra E; Contaldi P; Savastano S; Colao A
J Endocrinol Invest; 2011 Jul; 34(7 Suppl):18-22. PubMed ID: 21985975
[TBL] [Abstract][Full Text] [Related]
14. IGF-I receptor is required for the anabolic actions of parathyroid hormone on bone.
Wang Y; Nishida S; Boudignon BM; Burghardt A; Elalieh HZ; Hamilton MM; Majumdar S; Halloran BP; Clemens TL; Bikle DD
J Bone Miner Res; 2007 Sep; 22(9):1329-37. PubMed ID: 17539737
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of the serum stimulatory components of the insulin-like growth factor (IGF) system (IGF-I, IGF-II, IGF binding protein [BP]-3, and IGFBP-5) in age-related (type II) femoral neck osteoporosis.
Boonen S; Mohan S; Dequeker J; Aerssens J; Vanderschueren D; Verbeke G; Broos P; Bouillon R; Baylink DJ
J Bone Miner Res; 1999 Dec; 14(12):2150-8. PubMed ID: 10620075
[TBL] [Abstract][Full Text] [Related]
16. Basal bone phenotype and increased anabolic responses to intermittent parathyroid hormone in healthy male COX-2 knockout mice.
Xu M; Choudhary S; Voznesensky O; Gao Q; Adams D; Diaz-Doran V; Wu Q; Goltzman D; Raisz LG; Pilbeam CC
Bone; 2010 Aug; 47(2):341-52. PubMed ID: 20471507
[TBL] [Abstract][Full Text] [Related]
17. Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice.
Iida-Klein A; Zhou H; Lu SS; Levine LR; Ducayen-Knowles M; Dempster DW; Nieves J; Lindsay R
J Bone Miner Res; 2002 May; 17(5):808-16. PubMed ID: 12009011
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid hormone-(1-34) enhances aggrecan synthesis via an insulin-like growth factor-I pathway.
Harvey AK; Yu XP; Frolik CA; Chandrasekhar S
J Biol Chem; 1999 Aug; 274(33):23249-55. PubMed ID: 10438499
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid hormone increases the concentration of insulin-like growth factor-I and transforming growth factor beta 1 in rat bone.
Pfeilschifter J; Laukhuf F; Müller-Beckmann B; Blum WF; Pfister T; Ziegler R
J Clin Invest; 1995 Aug; 96(2):767-74. PubMed ID: 7635970
[TBL] [Abstract][Full Text] [Related]
20. Evidence that anabolic effects of PTH on bone require IGF-I in growing mice.
Miyakoshi N; Kasukawa Y; Linkhart TA; Baylink DJ; Mohan S
Endocrinology; 2001 Oct; 142(10):4349-56. PubMed ID: 11564695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
